Erratum: Focused Revision: Policy statement on folic acid and neural tube defects (Genetics in Medicine (2011) 13(6) (593–596), (S1098360021048103), (10.1097/GIM.0b013e31821d4188));Policy statement on folic acid and neural tube defects

Genetics in Medicine

Volumn 13, Issue 6, 2011, Pages 593-596

  Toriello, Helga V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

fortification; prevention; supplementation

Indexed keywords

CHOLINE; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN;

ANEMIA; ARTICLE; CANCER RISK; CLEFT LIP; CLEFT PALATE; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CYANOCOBALAMIN DEFICIENCY; CYTOTOXICITY; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; GASTROSCHISIS; GENETIC COUNSELING; GROUPS BY AGE; HEALTH CARE POLICY; HEALTH EDUCATION; HEARING LOSS; HEART ATRIUM SEPTUM DEFECT; HIGH RISK PREGNANCY; HUMAN; HYDROCEPHALUS; INSULIN RESISTANCE; KIDNEY MALFORMATION; LIFESTYLE; LIMB DEFECT; LUNG CANCER; MASKING; MEGALOBLASTIC ANEMIA; MORBIDITY; NATURAL KILLER CELL; NEURAL TUBE DEFECT; PANCREAS CANCER; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREGNANT WOMAN; PROSTATE CANCER; PYLORUS STENOSIS; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFECTION; URINARY TRACT MALFORMATION; VITAMIN SUPPLEMENTATION; WHEEZING;

EID: 79959250416     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/s41436-021-01226-6     Document Type: Erratum

References (51)

1. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51:944-950. (Pubitemid 8021028)
2. Laurence KM, James N, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981;282:1509-1511. (Pubitemid 11096562)
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338: 131-137.
4. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Def Res A Clin Mol Teratol 2007;79:737-742. (Pubitemid 350271820)
5. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260: 3141-3145.
6. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619. (Pubitemid 19193772)
7. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-1261. (Pubitemid 23067428)
8. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-226.
9. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relationship between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. N Engl J Med 1989;321:430-435.
10. Mills JL, Tuomilehto J, Yu KF, et al. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr 1992;120: 863-871.
11. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852. (Pubitemid 20002544)
12. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-1835. (Pubitemid 23003073)
13. Trussell J. The cost of unintended pregnancy in the United States. Contraception 2007;75:168-170. (Pubitemid 46217191)
14. Byrne J, Byrne C, Collins D. Trends in periconceptional folic acid use by relatives in Irish families with neural tube defects. Ir Med J 2001;94:302-305. (Pubitemid 34097674)
15. Rinsky-Eng J, Miller L. Knowledge, use and education regarding folic acid supplementation: continuation study of women in Colorado who had a pregnancy affected by a neural tube defect. Teratology 2002;66:S29-S31.
16. Wilton DC, Foureur MJ. A survey of folic acid use in primigravid women. Women Birth 2010;23:67-73.
17. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-39. (Pubitemid 34734388)
18. Lopez-Camelo JS, Orioli IM, da Graca Dutra M, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet 2005;135:120-125. (Pubitemid 40769959)
19. Bower C, D'Antoine H, Stanley FJ. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Def Res A Clin Mol Teratol 2009; 85:269-273.
20. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007;357:135-142. (Pubitemid 47057731)
21. Bol KA, Collins JS, Kirby RS; National Birth Defects Prevention Network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 2006;117:803-813. (Pubitemid 46063223)
22. Johnston RB Jr. Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: consideration of the evidence. Pediatr Res 2008; 63:2-8.
23. Botto LD, Lisi A, Bower C, et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 2006;76:693-705. (Pubitemid 44655984)
24. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Publ Health 2008;99:271-275.
25. Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Def Res A Clin Mol Teratol 2009;85:260-268.
26. Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the prostate, lung, colorectal, and ovarian screening trial. Am J Clin Nutr 2010;91:449-455.
27. Shannon J, Phoutrides E, Palma A, et al. Folate intake and prostate cancer risk: a case-control study. Nutr Cancer 2009;61:617-628.
28. Roswall N, Olsen A, Christensen J, Dragsted LO, Overvad K, Tjønneland A. Micronutrient intake and risk of colon and rectal cancer in a Danish cohort. Cancer Epidemiol 2010;34:40-46.
29. Durga J, Verhoef P, Anteunis LJ, Schouten E, Kok FJ. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann Intern Med 2007;146:1-9. (Pubitemid 351650315)
30. Cuskelly GJ, Mooney KM, Young IS. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 2007;66:548-558.
31. Hagberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009;94:180-184.
32. Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008;51:29-38. (Pubitemid 350197985)
33. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009;302:2119-2126.
34. Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006;136:189-194. (Pubitemid 43156507)
35. Selhub J, Morris MS, Jacques PF, Rosenberg IH. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr 2009; 89(suppl): 702S-706S.
36. Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009;12:30-36.
37. Rosenberg I. Getting folic acid nutrition right. Am J Clin Nutr 2010;91:3-4.
38. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-1669. (Pubitemid 28036827)
39. Rader JI, Schneeman BO. Prevalence of neural tube defects, folate status, and folate fortification of enriched cereal-grain products in the United States. Pediatrics 2006;117:1394-1399. (Pubitemid 46071534)
40. Shakur YA, Rogenstein C, Hartman-Craven B, Tarasuk V, O'Connor DL. How much folate is in Canadian fortified products 10 years after mandatory fortification? Canad J Publ Health 2009;100:281-284.
41. Mosley BS, Cleves MA, Siega-Riz AM, et al. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009;169:9-17.
42. Ray JG, Wyatt PR, Thompson MD, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007;18:362-366. (Pubitemid 46624947)
43. Molloy AM, Kirke PN, Troendle JF, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009;123:917-923.
44. Thompson MD, Cole DE, Ray JG. Vitamin B-12 and neural tube defects: the Canadian experience. Am J Clin Nutr 2009;89:697S-701S.
45. Li F, Watkins D, Rosenblatt DS. Vitamin B(12) and birth defects. Mol Genet Metab 2009;98:166-172.
46. Green R. Is it time for vitamin B-12 fortification? What are the questions? Am J Clin Nutr 2009;89:712S-716S.
47. Shaw GM, Finnell RH, Blom HJ, et al. Choline and risk of neural tube defects in a folate-fortified population. Epidemiology 2009;20:714-719.
48. American Academy of Pediatrics. Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1999;104:325-327.
49. Cheschier N; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin 44. Neural tube defects. Int J Gynecol Obstet 2003;83:123-133.
50. Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003-1026.
51. US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:626-631.